MBMammad A. Bagirov

Mammad A. Bagirov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mammad A. Bagirov has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Tumor eosinophilia in pulmonology practice

    by E. I. Shchepikhin, E. N. Adamovskaya, A. S. Zaitseva, M. V. Chashchina, A. S. Khozikov, M. A. Bagirov, Е. И. Щепихин, Е. Н. Адамовская, А. С. Зайцева, М. В. Чащина, et al.

    Aim. To present the current state of eosinophilia in hemoblastoses and solid tumors, illustrating the literature with clinical examples. A review of 33 foreign and domestic literature sources summarizes data on the pathobiology and clinical significance of tumor eosinophilia. Two clinical cases of hypereosinophilia in lymphoproliferative disease and solid tumors are presented. Conclusion. Peripheral blood eosinophils are an important diagnostic marker reflecting the severity of T2 inflammation and often predicting the effectiveness of anticytokine drugs that block IgE, IL-5, IL-4, IL-13, alarmins, and glucocorticosteroids. In clinical practice, it is important to consider that peripheral eosinophilia can also be an early marker of neoplastic processes, including solid tumors and lymphoproliferative and myeloproliferative diseases. Despite significant advances in pulmonary oncology and hematology, the Th2 immune response in general and eosinophilia in particular, both tissue and hematic, remain the focus of research interest. Further research has the potential to resolve the role and determine the place of eosinophilia as a prognostic and therapeutic biomarker.

  • Open Access

    Comprehensive treatment using surgical methods in a teenage patient with advanced fibrotic-cavernous pulmonary tuberculosis. Case report

    by Mamad A. Bagirov, Багиров Мамед Адилович, Ruslan V. Tarasov, Тарасов Руслан Вячеславович, Alexandra M. Zakharova, Захарова Александра Михайловна, Svetlana S. Sadovnikova, Садовникова Светлана Сергеевна, Andrey S. Khozikov, Хозиков Андрей Сергеевич

    According to the World Health Organization, approximately 12% of all diagnosed tuberculosis cases occur in children under 14 years of age. Notably, children account for 15% of the total deaths attributed to tuberculosis. The increasing drug resistance observed in Mycobacterium tuberculosis, combined with the limited effectiveness of non-surgical treatment options for complicated and drug-resistant tuberculosis, as well as the lower incidence of surgical interventions in pediatric and adolescent populations, highlights the pressing need to reevaluate management strategies for this demographic. Despite the significance of this issue, the literature addressing surgical interventions in pediatric patients remains scarce. This report presents a case of comprehensive treatment for a 17-year-old patient diagnosed with advanced fibrous-cavernous pulmonary tuberculosis The patient E. has been under the care of a tuberculosis specialist since 2018, following close contact with his infected mother. He began to exhibit symptoms in July 2020, including dyspnea and episodes of hyperthermia. Subsequent examinations on September 24, 2020, revealed pulmonary abnormalities, prompting treatment for 6 months. Upon further assessment, the patient was found to have developed resistance to isoniazid, rifampicin, and fluoroquinolones, requiring an adjustment to his therapeutic regimen. Throughout the treatment course, the patient experienced hemoptysis, with blood loss reaching approximately 10 mL per day; this complication was effectively resolved through hemostatic therapy. Computed tomography scans identified multiple lung cavities of varying sizes, the largest measuring 29×25×38 mm. A thorough fibrobronchoscopy did not identify the source of the hemoptysis. To address the recurrent hemoptysis in accordance with the radiological findings, a staged surgical intervention was undertaken. The first stage involved a combined resection of the left lung, consisting of upper lobectomy and partial resection of the S6 segment. An artificial pneumoperitoneum of 1000–1200 mL was used weekly for three months to facilitate cavity compression and induce a collapsogenic effect. Following a five-month interval, the patient underwent a second surgical procedure, which entailed a combined resection of the right lung, consisting of upper lobectomy and the precise excision of the S4 lesion. The treatment lasted 14 months, from the presentation to the end of therapy. The optimal outcome in this adolescent patient was achieved through a multifaceted approach that included staged surgical interventions, tailored individualized therapies during both pre- and postoperative periods, and the implementation of a collapsotherapy.

  • Staged surgical treatment of patients with bilateral pulmonary tuberculosis with indications for pneumonectomy

    by V.K. Aliev, A.E. Ergeshova, S.S. Sadovnikova, A.S. Polyakova, G.A. Asoyan, M.A. Bagirov, A.E. Ergeshov

    Objective. To improve treatment effectiveness in patients with bilateral pulmonary tuberculosis and indications for pneumonectomy. Material and methods. A retrospective analysis enrolled 25 patients who underwent surgery between 2012 and 2025. All patients underwent staged surgical treatment, including pneumonectomy and surgery on the contralateral lung. Patients were divided into two groups: group 1 (n=12) — pneumonectomy combined with lung resection; group 2 (n=13) — pneumonectomy combined with collapse surgery (predominantly extrapleural pneumonolysis with silicone implant placement). Results. Pneumonectomy at the first stage was often a forced measure due to urgent indications or the need to eliminate the main reservoir of infection. In elective cases, less traumatic interventions were preferable at the first stage. In the 1st group, postoperative complication rate was significantly higher (p<0.05) compared to the 2nd group without 30-day complications. There was no in-hospital mortality. The five-year survival rate after all surgical stages was 89% and 67% in both groups, respectively. The main cause of long-term mortality was progression of tuberculosis. Conclusion. Resection of the less affected lung is preferable at the first stage if functional reserves are normal. Collapse surgery is indicated in patients with low reserves. Collapse surgery demonstrates higher safety in immediate postoperative period. Adherence to treatment is a key factor for long-term success.

  • Radical elimination of complications following staged complex surgical treatment of pulmonary tuberculosis

    by M.A. Bagirov, S.S. Sadovnikova, V.K. Aliev, I.YU. Shabalina, M.V. Chashchina, I.V. Sivokozov

    Objective. To analyze surgical management of tuberculosis and main bronchus stump fistula after failed surgical treatment and vascular occluders. Material and methods. Two cases are presented. The study included patients with Amplatzer ASD occluders placed for bronchopleural complications after pneumonectomy. Transsternal occlusion of the main bronchus was performed for surgical correction of complications. Results. The authors demonstrate effective staged surgical treatment of the main bronchial stump fistula after failed surgical management with vascular occluder. Conclusion. Surgical treatment after failed closure of the main bronchial stump fistula with vascular occluders under persistent infection and empyema is an extremely complex staged approach. This management should consider all previous surgeries and endoscopic interventions, can last for several years and requires a highly qualified team of thoracic surgeons.

  • Specifics of surgical treatment of patients with limited pulmonary tuberculosis depending on their HIV-status

    by Georgiy V. Chitorelidze, Larisa N. Lepekha, Bekhrus U. Salikhov, Vilayat K. Aliev, Alexandr V. Papkov, Natalya L. Karpina, Mamad A. Bagirov, Салихов Бехруз Умаркулович

    BACKGROUND: Pulmonary tuberculosis presents a serious problem in HIV-infected patients, as it often progresses to severe forms and increases the risk of death. Surgical treatment of this category of patients is difficult because of a high risk of complications associated with immunodeficiency and specifics of the course of tuberculosis. AIM: To analyze the features of surgical treatment of patients with limited pulmonary tuberculosis (LPT) depending on their HIV-status. METHODS: The study included 62 patients with LPT, divided into two groups: HIV-infected (main group; n = 27 individuals, CD4 level 200 cells/μl) and HIV-negative (comparison group; n = 35). In both groups, men predominated: 55.6% (15/27) in the main group and 62.8% (22/35) in the comparison group. The mean age in the groups was 39.2 ± 0.9 and 40.3 ± 1.1 years respectively (p 0.05). The groups were comparable in the duration of anti-tuberculosis therapy; in both groups, the majority of patients had a history of anti-tuberculosis treatment for 2 years or more. Only in 11.1% (3/27) of cases in the main group and in 14.3% (5/35) in the comparison group, the surgical stage of treatment was performed during the first year of anti-tuberculosis chemotherapy. RESULTS: HIV-infected patients more often presented with prominent fibrous alterations in the lung tissue and lymph nodes, which created technical difficulties during surgery and increased the risk of intraoperative complications (33.3% versus 11.4% in HIV-negative patients, p 0.05). A tendency to a higher incidence of postoperative complications was recorded in HIV-infected patients with LPT (22.2% versus 8.6%, p 0.05). The effectiveness of surgical treatment was comparable in both groups (92.6% in HIV-infected and 97.1% in HIV-negative, p 0.05). CONCLUSION: HIV-infection in patients with LPT is a risk factor for the development of intra- and postoperative complications. Surgical treatment of this category of patients requires particular care and attention to potential difficulties conditioned by specifics of the course of the disease.

  • Analysis of predictive risk factors of postoperative complications in patients with non-tuberculous mycobacterial pulmonary disease and the combination of tuberculosis — non-tuberculous mycobacterial pulmonary disease

    by Margarita V. Chashchina, Natalya L. Karpina, Irina Yu. Shabalina, Svetlana S. Sadovnikova, Mamed A. Bagirov, Danila A. Yakubets

    Aim. To assess the structure of postoperative complications in patients with Non-tuberculous mycobacterial pulmonary disease (NTM-PD) and the combination of «Tuberculosis — non-tuberculous mycobacterial pulmonary disease» (TB/ NTM-PD), to conduct a statistical analysis of the risk factors for their development in the early and late postoperative periods with the design of a predictive model. Materials and methods. The results of 150 surgeries performed on 145 patients were analyzed. Group 1 (n=44) included patients with an initial diagnosis A16.0 according to ICD-10 (pulmonary tuberculosis (TB) with negative results of bacteriological and histological stud-ies, «TB without etiological verification») and a diagnosis of NTM-PD established during the examination of surgical material. Group 2 (n=64) consisted of patients with NTM-PD diagnosed prior to surgery who underwent surgical treatment for NTM-PD. Group 3 (n=37) included patients with combined pathology «TB/NTM-PD». To study risk factors for bronchopleural complications, 111 patients were selected: 21 cases with postoperative complications (18.9%), and 90 cases without complications (81.1%); all of whom underwent endoscopic examination in the preoperative period. A multifactorial analysis of complications was performed with the development of a predictive model. Results. As a result of the research conducted, it was found that: there were no complications in patients with an initial diagnosis of A 16.0 and a diagnosis of NTM-PD verified during the examination of surgical material (group 1); in patients with preoperative NTM-PD (group 2), only complications of the early postoperative period were recorded — 6.6% (10/150); in patients with «TB/ NTM-PD» (group 3), a total of 7.3% (11/150) cases of postoperative complications were detected (including 3.3% (5/150) cases of late postoperative period). Factors potentially associated with the risk of bronchopleural complications in the postoperative period have been identified: endobronchial pathology (p<0.0001), history of smoking (continues to smoke) (p=0.0009), combined lung resection (p=0.0009), pleural obliteration (p=0.0987). A prognostic model of complications with high predictive ability was construct-ed with satisfactory compliance indicators: sensitivity (57.14%), specificity (96.67%), AUC-ROC=0.88; R2 (Tjur’s R squared) = 0.3910. Conclusion. The prognostic model based on the identified risk factors (endobronchial pathology (history of smoking (continues to smoke), combined lung resection, pleural obliteration) will allow to predict the development of complications in the postoperative period in 57.14% (sensitivity) of cases and identify patients without a complicated postoperative period in 967% (specificity).

  • View on the expediency of surgical treatment for pulmonary tuberculosis

    by R. V. Tarasov, L. N. Lepekha, E. V. Krasnikova, M. A. Titova, M. A. Bagirov

    A review of the literature sources contained in the databases of RSCI, Google Scholar, PubMed, and Scopus for the period from 1966 to 2024, as well as their own observations on the treatment of patients diagnosed with pulmonary tuberculosis, was conducted. The analysis of morphological, microbiological, clinical and long-term results of surgical treatment is presented, on the basis of which it is concluded that a surgical stage is necessary in the complex treatment of pulmonary tuberculosis.

  • Open Access

    The difficulties of treating patients with postresection pleural empyema and bronchopleural fistulas

    by Mamad A. Bagirov, Ruslan V. Tarasov, Svetlana S. Sadovnikova, Sofiya S. Popova, Andrey S. Khozikov, Хозиков Андрей Сергеевич

    A case report is presented – surgical treatment of a patient with right-sided postresection tuberculous empyema and bronchopleural fistula after surgery. Patient T., 20 years old, has suffered from tuberculosis since the fall of 2019. On 02.10.21, a lower lobectomy was performed on the right side. In the postoperative period, air discharged through drains was suspected of failing the bronchial stump, which led to another operation: retoractomy, revision of the pleural cavity on the right, and medium lobectomy. According to CT scans of the OGC, there was residual pleural tissue, and the failure of the middle bronchus stump was confirmed. She visited the FSBI "TSNIIT" complaining of shortness of breath during exercise, and a feeling of discomfort in her right chest when breathing deeply. On July 27, 21, re-amputation of the intermediate bronchial stumps was performed. The residual pleura remained after the operation, and drains were removed after 1,5 month. PPI was given at a dose of 1,200 mL/week. Fourteen days later, a control scan of the lungs revealed residual pleural space. Due to the inability to drain the right pleural cavity after several attempts, a revision of the VATS of the right pleura, pleurodesis was performed. The surgery was without complications, the stump was sealed. Drains were removed 2.5 months after achieving hermiticism. With control CT scans of OGK at 1 and 3 years after surgery, AKI was not detected, and the dome of the diaphragm was raised on the right side, with a fibrothorax in the upper parts. She completed treatment and returned to a normal lifestyle.

  • Open Access

    Tuberculosis of peripheral lymph nodes in adolescents as a manifestation of a generalized specific process: Clinical case

    by Lyudmila V. Panova, Tatiana N. Borisova, Elena S. Ovsyankina, Mamad A. Bagirov

    Tuberculosis of peripheral lymph nodes is extremely rare, so when patients first contact a pediatrician due to enlargement of lymph nodes, it may be challenging to establish the correct diagnosis. To conduct a differential diagnosis between tuberculosis and nonspecific diseases, it is necessary to consider the medical history, paying special attention to the presence of contact with a patient with tuberculosis, and conducting a set of tests available to pediatricians and surgeons in general polyclinics and hospitals. The presented clinical case demonstrates the missed opportunities for timely diagnosis of tuberculosis in an adolescent, which led to the generalization of the specific process with involvement of peripheral lymph nodes and required several surgical interventions.

  • Open Access

    Differential Diagnosis of Peripheral Lung Lesions: Capabilities and Limitations of Current Methods

    by R. N. Islamov, R. A. Sharipov, M. A. Bagirov, R. K. Tukfatullin, G. V. Chitorelidze, E. V. Pavlova, R. K. Yagafarova

    This article analyzes 63 scientific works dedicated to the diagnosis of peripheral lung lesions (PLL). The differential diagnosis of PLL poses challenges due to the diversity of underlying pathologies, which may include tuberculoma, cancer, and benign tumors. The absence of a unified diagnostic algorithm often necessitates surgical intervention. Non-invasive methods, including radiography, computed tomography (CT), positron emission tomography (PET), and sputum analysis, exhibit limited diagnostic yield, particularly for small lesions. The combination of fiberoptic bronchoscopy with endoscopic ultrasound (EUS) and transthoracic biopsy enhances diagnostic accuracy; however, they carry risks such as pneumothorax. Video-assisted thoracoscopic surgery (VATS) is an effective modality when biopsies are inconclusive, especially for lesions of less than 3 cm. It ensures high diagnostic accuracy and reduces hospitalization duration. Videoassisted thoracoscopic biopsy offers diagnostic accuracy comparable to that of open biopsy, while exhibiting reduced invasiveness. Conventional thoracotomy remains indicated for large or hard-to-reach lesions. It is recommended that a comprehensive approach combining CT, characterized by high informative value, and PET scan, characterized by high sensitivity and specificity for nodules >10 mm, with invasive methods be used. VATS proves effective for lesions below 3 cm, while thoracotomy is applied to large lesions. An individualized approach remains essential for optimal diagnosis. Despite the advancements, the challenge of differential diagnosis persists.